Goodwin Procter LLP advised CRISPR Therapeutics on the deal.CRISPR Therapeutics (NASDAQ: CRSP) announced its collaboration agreement with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to develop, manufacture, and commercialize…
CRISPR Therapeutics’ Collaboration Agreement with Vertex Pharmaceuticals


























